Table 3.
Cat | Local recurrence | Additional skin nodules | Metastasis | Outcome | Follow-up (d) | DFS (d) | OS at last follow-up (d) |
---|---|---|---|---|---|---|---|
1 | + | + | + | Deceased (FPH) | 84 | 49 | 84 |
2 | – | – | ND | Unknown | 980 | ≥980 | ≥980 |
3 | – | – | ND | Alive | 1,449 | ≥1,449 | 1,449 |
4 | – | – | ND | Alive | 1,438 | ≥1,438 | 1,438 |
5 | + | – | – | Euthanized | 788 | ND | 788 |
6 | + | + | ND | Alive | 1,218 | ND | 1,218 |
7 | – | + | Suspected | Euthanized (FPH) | 127 | 21 | 127 |
8 | – | – | ND | Alive | 1,147 | ≥1,147 | 1,147 |
9 | – | + | Suspected | Euthanized | 76 | 60 | 76 |
10 | – | – | ND | Euthanized | 852 | 852 | 852 |
11 | – | + | + | Euthanized (FPH) | 96 | 0 | 96 |
12 | + | + | ND | Euthanized (FPH) | 175 | 53 | 175 |
13 | – | – | ND | Euthanized | 45 | ND | 45 |
14 | – | – | ND | Unknown | 12 | ≥12 | U |
15 | U | U | ND | Unknown | 0 | U | U |
16 | – | – | ND | Alive | 321 | ≥321 | 321 |
17 | U | U | ND | Unknown | 0 | U | U |
18 | – | + | ND | Euthanized (FPH) | 41 | ND | 41 |
19 | – | – | Suspected | Euthanized | 126 | ND | 126 |
20 | U | U | ND | Unknown | 0 | U | U |
21 | – | + | ND | Euthanized (FPH) | 66 | 0 | 66 |
22 | + | + | ND | Euthanized | 735 | 309 | 735 |
23 | – | – | ND | Unknown | 8 | ≥8 | ≥8 |
24 | – | – | ND | Unknown | 1,010 | U (≥1,010) | U (≥1,010) |
25 | – | – | + | Euthanized (FPH) | 113 | ND | 113 |
26 | + | + | ND | Euthanized (FPH) | 238 | 208 | 238 |
Deceased/euthanized (FPH) = dead of feline progressive histiocytosis; DFS = disease-free survival; ND = not determined; OS = overall survival; U = unknown.